Literature DB >> 7563111

Possibilities for the pharmacological exploitation of ischaemic preconditioning.

J R Parratt1.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7563111     DOI: 10.1016/0022-2828(95)90068-3

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  12 in total

1.  Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response.

Authors:  A Clerk; J Gillespie-Brown; S J Fuller; P H Sugden
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

Review 2.  Endothelial cells, nitric oxide and ischaemic preconditioning.

Authors:  J R Parratt; A Vegh
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

Review 3.  Criteria for a mediator or effector of myocardial preconditioning: do KATP channels meet the requirements?

Authors:  G J Gross; D A Mei; J J Schultz; T Mizumura
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

4.  Protection from preconditioning can be reinstated at various reperfusion intervals.

Authors:  E K Iliodromitis; C Papadopoulos; I A Paraskevaidis; Z S Kyriakides; C Flessa; D T Kremastinos
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

5.  Activation of cardiac muscarinic receptor and ischemic preconditioning effects in in situ rat heart.

Authors:  F Yamaguchi; Y Nasa; K Yabe; S Ohba; Y Hashizume; H Ohaku; K Furuhama; S Takeo
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

6.  Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart.

Authors:  Peter Dazert; Konrad Meissner; Silke Vogelgesang; Björn Heydrich; Lothar Eckel; Michael Böhm; Rolf Warzok; Reinhold Kerb; Ulrich Brinkmann; Elke Schaeffeler; Matthias Schwab; Ingolf Cascorbi; Gabriele Jedlitschky; Heyo K Kroemer
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  Alterations in circulating cyclic guanosine monophosphate (c-GMP) during short and long ischemia in preconditioning.

Authors:  E K Iliodromitis; C C Papadopoulos; M Markianos; I A Paraskevaidis; Z S Kyriakides; D T Kremastinos
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

8.  A common mechanism in the protective effects of preconditioning, cardiac pacing and physical exercise against ischemia and reperfusion-induced arrhythmias.

Authors:  Agnes Végh; James R Parratt
Journal:  Exp Clin Cardiol       Date:  2005

9.  Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.

Authors:  A Lochner; S Genade; E Tromp; L Opie; J Moolman; S Thomas; T Podzuweit
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

10.  Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: role of polyprenyl derivatives and nitric oxide.

Authors:  P Ferdinandy; C Csonka; T Csont; Z Szilvássy; L Dux
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.